证券记录 · 已归档季度
MDXG
MiMedx Group, Inc. · Healthcare · Biotechnology
16被追踪持有人
0Δ持有人
31.16M持有股份
$190.41M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +2.8% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 90 | 0 | 52.34M | $201.56M | +8 | −8 |
| Q1 2026 | 93 | 0 | 53.34M | $210.99M | +4 | −4 |
| Q4 2025 | 93 | +1 | 51.21M | $346.71M | +1 | n/a |
| Q3 2025 | 19 | 0 | 33.28M | $232.30M | n/a | n/a |
| Q2 2025 | 16 | 0 | 31.16M | $190.41M | +1 | −1 |
| Q1 2025 | 13 | -1 | 11.80M | $89.67M | n/a | −1 |
| Q4 2024 | 14 | +1 | 11.42M | $109.89M | +1 | n/a |
| Q3 2024 | 12 | -2 | 7.09M | $41.90M | n/a | −2 |
| Q2 2024 | 14 | n/a | 7.86M | $54.46M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 11.53M | n/a | $70.42M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (被动) | 6.96M | n/a | $42.51M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (被动) | 3.47M | +0.2% | $21.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 2.84M | -2.4% | $17.37M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Renaissance Technologies ✦ | 2.11M | +9.2% | $12.88M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 6 | Millennium Management ✦ | 1.67M | +35.9% | $10.22M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 791.78K | +30.5% | $4.84M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 452.67K | +1.5% | $2.77M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 379.16K | 新增 | $2.32M | 0.0% | New | 1 | SEC ↗ ×2 |
| 10 | Wellington Management ✦ | 351.73K | -6.6% | $2.15M | 0.0% | ▼ Trim | 5 | SEC ↗ ×3 |
| 11 | Fisher Asset Management ✦ | 273.00K | 0.0% | $1.67M | 0.0% | Held | 5 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 102.88K | -68.3% | $628,609 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 98.96K | -2.3% | $604,664 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 79.30K | +54.9% | $486,000 | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 15 | AQR Capital Management ✦ | 33.94K | +136.1% | $207,355 | 0.0% | ▲ Add | 3 | SEC ↗ ×4 |
| 16 | Fidelity (FMR) ✦ | 25.90K | n/a | $158,264 | 0.0% | n/c | 1 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $2.32M | 0.0% |
已清仓
| Norges Bank | $535,040 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 234 持有人, 112.82M 股份, $439.18M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据